|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
|||||||||||||||||||
|
|||||||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sAA0A820C-348D-11EF-A8CD-08B584CE164B&I=39IZM&T=&OP=Display&O=html&O1=12626819&O2=954925416981&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DProgress%2520and%2520Challenges%2520in%2520Developing%2520Medical%2520Countermeasures%2520for%2520Chemical%252C%2520Biological%252C%2520Radiological%252C%2520and%2520Nuclear%2520Threat%2520Agents%26rft.au%3DReddy%252C%2520Doodipala%2520Samba%26rft.date%3D2024-02-01%26rft.eissn%3D1521-0103%26rft.externalDocID%3D38233227%26rft.genre%3Darticle%26rft.issue%3D2%26rft.jtitle%3DThe%2520Journal%2520of%2520pharmacology%2520and%2520experimental%2520therapeutics%26rft.spage%3D260%26rft.volume%3D388%26rft_id%3Dinfo%253Adoi%252F10.1124%252Fjpet.123.002040%26rft_id%3Dinfo%253Apmid%252F38233227%26rft_id%3Dinfo%253Apmid%252F38233227%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-UNPAYWALL-getFullTxt-object,2-CANADIAN_LIBRARIES-getFullTxt-object,3-GFMER_FREE_MEDICAL_JOURNALS-getFullTxt-object,4-COBIB_SI_LCL-getHolding-object,5-DOI-getDOI-object,6-EBSCOHOST_APA_PSYCINFO-getAbstract-object,7-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,8-ISI_WEB_OF_SCIENCE-getAuthor-object,9-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,10-REFWORKS_EXPORT_TOOL-getReference-object,11-NCBI_PUBMED_FREE-getCitedRecord-object,12-SHERPA_RoMEO_LCL-getWebService-object,13-GOOGLE_SCHOLAR_FREE-getWebSearch-object,14-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.863596&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:12626819-sAA0A820C-348D-11EF-A8CD-08B584CE164B" timestamp="2024-06-27T16:00:52Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954925416981</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Progress and Challenges in Developing Medical Countermeasures for Chemical, Biological, Radiological, and Nuclear Threat Agents</jnl:atitle>
<jnl:jtitle>Journal of Pharmacology and Experimental Therapeutics</jnl:jtitle>
<jnl:date>2024-02-17</jnl:date>
<jnl:spage>260</jnl:spage>
<jnl:epage>267</jnl:epage>
<jnl:coden>JPETAB</jnl:coden>
<jnl:issn>0022-3565</jnl:issn>
<jnl:volume>388</jnl:volume>
<jnl:issue>2</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1521-0103</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:coden>JPETAB</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:00ef2770f376b5ae7aa791cd799699b9917a2680</ctx:identifier>
<ctx:identifier>urn:UUID:sAA0A820C-348D-11EF-A8CD-08B584CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)